Welcome!

Agile Computing Authors: John Katrick, Liz McMillan, LeanTaaS Blog, Progress Blog, Derek Weeks

Related Topics: @CloudExpo, Java IoT, Microservices Expo, Containers Expo Blog, Agile Computing, @DXWorldExpo

@CloudExpo: Article

Cloud Platforms: The Crucial Foundation | @CloudExpo #IoT #Microservices

How a cloud environment can offer the flexible resources, elastic scalability and system reliability

Cloud Platforms: The Crucial Foundation to Safeguard the Pharmaceutical Supply Chain

In today's pharmaceutical supply chain, counterfeit activity is thriving. As pharma companies have expanded target markets and outsourced production over the last decade, the supply chain has become increasingly global, virtual, and vulnerable. Illicit activity has thrived, and patients have suffered, with hundreds of thousands dying each year from counterfeit and contaminated drugs.

More than 40 countries have responded with new laws that regulate prescription medications as they travel through the supply chain. While this is a quantum leap forward for patient health, the implications for supply chain stakeholders, from pharmaceutical companies and their contract manufacturing partners to the pharmacies that serve patients are daunting: they must master each country's disparate track and trace requirements; create a system architecture capable of generating, managing, and storing what will be unprecedented volumes of regulated data; and figure out how to efficiently exchange that data with hundreds to tens of thousands of direct and indirect supply chain partners.

In the process, traditional technology will be put to the test. Traditional, on-premises data center and enterprise software infrastructure will prove incapable of meeting the enormous data management and transactional processing demands that compliance will introduce. Cloud computing networks offer the only practical solution for this challenge.

This article will discuss the how a cloud environment can offer the flexible resources, elastic scalability and system reliability required to meet compliance regulations and patient safety protections necessitating the tracking and tracing of medications through every step of the supply chain.

From Local to Global: Increasingly Virtual and Vulnerable
Emerging market demand for medicines has skyrocketed in the past decade and a better understanding of patient health has driven a parallel growth of increasingly specialized medicines. In response, the pharmaceutical supply chain has shifted from predominantly a local presence, with local pharmaceutical companies producing medicines for the local market, to a truly global supply network linking diverse members across multiple continents to serving global patient populations. On this global network now flows an increasingly broad range of medicines, driving pharmaceutical companies to virtualize many operations and establish complex new supply relationships in order to reach and serve a global, increasingly diverse market.

Many have built relationships with local contract manufacturers, pharmaceutical companies and third-party logistical organizations for production and distribution efficiencies. These partnerships have allowed them to decrease fixed costs, improve agility and enhance access to the global market by cost-effectively producing and distributing product around the world. This growth creates vulnerability as a longer supply chain with more changes of possession and ownership from drug manufacturing to patient dispensation creates more opportunity for counterfeiting and diversion.

The true scope of counterfeiting - which encompasses everything from inactive or incorrect ingredients to drugs with high levels of contaminants or fake packaging - is unknown, but the World Health Organization (WHO) estimates that between 1% and 10% of drugs sold around the world are impacted, and the overall worldwide sale of counterfeit drugs is valued at more than $75 billion a year. The cost to patient safety: immense.

The Response: Track and Trace Regulation
In response to increasing drug integrity concerns, more than 40 countries from the U.S., China, India, South Korea, Brazil and the members states of the European Union have introduced track and trace laws to identify, track, and verify product as it passes through the supply chain. By 2019, more than 75% of the world's prescription medications will be protected by legislation. From a patient health perspective, this is unequivocally good news.

For the industry, however, these diverse regulations introduce a web of challenges. While most regulations involve some combination of generating and managing serial numbers for each unit of drug product, tracking product through the supply chain, verifying data and transactions at various points in the network, and reporting associated events to government authorities, no two countries in the world have passed the same requirements or mandated the same information formats. This is particularly problematic when you consider that globally tens of billion units of drug product are produced and distributed annually across a global supply network made up of well over one million members.

Global Track and Trace Breaks Traditional Enterprise Approaches
Track and trace compliance demands test - and surpass - the limits of what traditional technology and enterprise infrastructures can manage in two key areas: big data management, and trading partner integrations. Let's look at what a mid-sized pharmaceutical company serving the United States market may face under the Drug Supply Chain Security Act (DSCSA). Our model company may produce 50 million units of drug product annually for the U.S. market. All 50 million units need unique serial numbers generated along with the 1 million cases that they are packed in. Each serialized unit will generate an average of 5 serialized events needing to be managed, resulting in 255 million serialization transaction events and more than 255 gigabytes of compliance data at 1 kilobyte per event annually. Across a 10 year record retention period, the company would be faced with securely managing over 2.5 billion compliance events and over 2.5 terabytes of compliance data.

The network challenges are just as daunting. A mid-sized company may use a dozen or more contract partners to augment internal sites to produce their serialized products for different markets. All of these sites and their different serialization line management systems need to be integrated with across multiple transactions. Even more difficult are the downstream network connection challenges. Dozens to hundreds of direct trading partners, including wholesale distributors, repackagers and dispensers need to be connected for lot-level traceability and serialized product data exchange as products are sold, distributed, returned and verified during investigations. Add in the requirement to receive and respond to serialized product verification requests from thousands of indirect trading partners such as independent pharmacies and the pharmaceutical manufacturer faces an unprecedented challenge. This intricate, highly connected serialized supply network will now need high performance electronic connections over which millions of transactions and gigabytes of compliance data will flow.

The U. S. DSCSA example is just one of the many scenarios facing multi-national pharmaceutical companies. All in all, an in-house infrastructure to support this network ecosystem would be prohibitively expensive and complicated from a capital, personnel, and expertise perspective. Because of the dynamic nature of global track and trace regulations, companies making large capital investments in their physical IT infrastructure also take on unacceptable risks as regulatory environments and their related data management requirements may change on a yearly or even quarterly basis.  Given the volume and complexity of required partner connections, an individual, point-to-point approach built upon traditional enterprise infrastructures using standard SQL database is just not feasible. This is why Life Sciences must look to the cloud for a solution.

Network-based Cloud Platforms Are the Only Way to Meet Emerging Needs
In order to succeed in the new global, virtual, and regulated landscape, the Life Sciences supply chain needs a new data exchange model and supporting platform that can scale to manage trillions of objects and transactions, and handle seamless exchange of this data amongst global supply chain partners that number over a million worldwide. Plus, as personalized medicine, patient regimen compliance and other patient engagement programs are developed across the industry, this platform will need to connect to the billions of patients globally receiving medicines. The industry needs a platform that can facilitate communications, generate efficiencies, guarantee compliance and protect information - and do all of that in a cost-effective manner.

Cloud computing infrastructures such as Amazon's AWS Cloud, utilizing global, on-demand data and transaction processing resources, ticks all of the requisite boxes. Yet, cloud environments come in several different flavors, so it's important to understand which design and configurations will meet emerging challenges facing the industry.

Public vs. Private
A private cloud - dedicated to only your company - offers limited elasticity within your private data center, while a public cloud is a true utility computing model. For the reasons of scalability, along with solid disaster recovery and security, a public cloud model makes the most sense to support the pharmaceutical supply chain.

Single, Multi-, and Network-Tenant Environments
In the new pharmaceutical regulatory environment, understanding the attributes of single-, multi-, and network-tenant clouds is critical to a company's ability to exchange required data with their full complement of internal sites, supply and trading partners. The goal is to find the right infrastructure that supports the necessary data, transactional and connectivity requirements.

A single-tenant architecture is a legacy approach that creates a separate software instance and supporting infrastructure for each customer and their data. This type of architecture will not support sharing compliance data with many partners or evolving regulations which necessitate regular updates.

In a multi-tenant setup, a single instance of software and the infrastructure serves multiple parties. Multi-tenancy is a step forward from single tenancy, but it does not explicitly facilitate connectivity and communication between companies.

Network-Tenancy for Mission-Critical Life Sciences
Network tenancy is a whole new dimension that builds on multi-tenancy, but was expressly created to meet the challenges of today's Life Sciences companies.

The fundamental purpose of a network-tenant environment is to enable interactions and share business processes across multiple companies on the network, establishing a new dimension of collaboration with existing partners and allowing for discoverability of new partners within a directory structure.

In a network-tenant solution, interactions with other companies are a paved road and a singular process: you integrate into the network once, and can then interact with everyone. Network tenancy also provides data translation and transportation, enabling seamless information exchange in a regulatory world with incomplete standards and diverse corporate data preferences. Think of it like the Interstate highway or the electrical grid ensuring free flow across the network while enabling diverse entities to join.

Service providers distribute software updates to all network residents simultaneously, insuring that all companies remain in compliance as regulations continue to evolve. Network tenancy builds on the security protocols of multi-tenancy, protecting data and the private network interactions while enhancing interoperability and business growth by adding new forms of public discovery and inquiry across the network similar to those seen in consumer networks like LinkedIn. Well-defined network tenant platforms add additional layers of security by invoking a rigorous process of vetting new members prior to adding them to the network.

Specifically for Life Sciences, network tenant platforms must go one step further. The systems deployed must be designed to meet regulatory requirements in areas like validation while ensuring overall system integrity and reliability as critical medicines are produced and distributed. The platform and the processes used to build solutions on the platform must minimize and isolate change that impact validated systems while providing detailed IQ and OQ artifacts to support validation testing on new platform releases. In addition, inherent fail-over and redundancy must be designed in from the start for both data management and transaction processing.

Done right, network tenancy enables residents to share compliance-related business processes with diverse global supply and trading partners; seamlessly exchange data in a world without format standards; accommodate the massive scale demands of global serialization; and grow their businesses by supporting global supply relationships and discovery of new prospective partners. It also lays the foundation for new business value as any one network member now has global connection and reach to leverage for new forms of supply planning and patient engagement. It is the only solution that can accommodate the evolving needs of the fast growing Life Sciences supply chain.

Choosing the Right Solution for Success
By 2017, the global prescription drug market is projected to grow to $1.2 trillion, up from $900 billion in 2014. Counterfeit activities are also poised to accelerate. The stakes are high - and there's no question that network tenant cloud platforms not only change the game but are a necessary unpinning for this highly regulated and fast evolving environment.

As outlined here, a public, network-tenant cloud environment that offers flexible interoperability and global elasticity will support businesses as they roll-out serialization and track and trace solution. It will make connecting with global trade partners and exchanging data as simple as integrating to the platform once, and then interoperating with everyone. It will create a global network for collaboration and enable the smallest emerging biopharma or street corner pharmacy to enjoy the same global computing firepower and capabilities as the largest global pharmaceutical company.

The right platform will also level the playing field in terms of technical resources will support tighter financial accountability. Most importantly, though, the right networked-cloud environment is the only way to comprehensively track medications through every step of the supply chain, and truly protect patient safety.

More Stories By Brian Daleiden

Brian Daleiden is Vice President of Industry Marketing at TraceLink, a company focused on helping pharmaceutical manufacturers, distributors and dispensers deliver safe prescription medicines to patients everywhere with the largest track and trace network in the Life Sciences industry. In this capacity, he leads the company’s thought leadership, global regulatory analysis and market education programs that help industry stakeholders understand and respond to emerging regulatory, business and technical requirements.

Brian holds an MBA from Vanderbilt University and a BS from the University of Wisconsin. Brian can be reached at [email protected]

Comments (0)

Share your thoughts on this story.

Add your comment
You must be signed in to add a comment. Sign-in | Register

In accordance with our Comment Policy, we encourage comments that are on topic, relevant and to-the-point. We will remove comments that include profanity, personal attacks, racial slurs, threats of violence, or other inappropriate material that violates our Terms and Conditions, and will block users who make repeated violations. We ask all readers to expect diversity of opinion and to treat one another with dignity and respect.


@ThingsExpo Stories
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, discussed some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he covered some of the best practices for structured team migration an...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
22nd International Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, and co-located with the 1st DXWorld Expo will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud ...
DevOps at Cloud Expo – being held June 5-7, 2018, at the Javits Center in New York, NY – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Among the proven benefits,...
@DevOpsSummit at Cloud Expo, taking place June 5-7, 2018, at the Javits Center in New York City, NY, is co-located with 22nd Cloud Expo | 1st DXWorld Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
SYS-CON Events announced today that T-Mobile exhibited at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on qua...
SYS-CON Events announced today that Cedexis will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Cedexis is the leader in data-driven enterprise global traffic management. Whether optimizing traffic through datacenters, clouds, CDNs, or any combination, Cedexis solutions drive quality and cost-effectiveness. For more information, please visit https://www.cedexis.com.
SYS-CON Events announced today that Google Cloud has been named “Keynote Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Companies come to Google Cloud to transform their businesses. Google Cloud’s comprehensive portfolio – from infrastructure to apps to devices – helps enterprises innovate faster, scale smarter, stay secure, and do more with data than ever before.
SYS-CON Events announced today that Vivint to exhibit at SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California. As a leading smart home technology provider, Vivint offers home security, energy management, home automation, local cloud storage, and high-speed Internet solutions to more than one million customers throughout the United States and Canada. The end result is a smart home solution that sav...
SYS-CON Events announced today that Opsani will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Opsani is the leading provider of deployment automation systems for running and scaling traditional enterprise applications on container infrastructure.
SYS-CON Events announced today that Nirmata will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Nirmata provides a comprehensive platform, for deploying, operating, and optimizing containerized applications across clouds, powered by Kubernetes. Nirmata empowers enterprise DevOps teams by fully automating the complex operations and management of application containers and its underlying ...
SYS-CON Events announced today that Opsani to exhibit at SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California. Opsani is creating the next generation of automated continuous deployment tools designed specifically for containers. How is continuous deployment different from continuous integration and continuous delivery? CI/CD tools provide build and test. Continuous Deployment is the means by which...